Cord Blood News Volume 7.29 | Jul 30 2015

Long-Term Sustained Disease Control in Patients with Mantle Cell Lymphoma with or without Active Disease after Treatment with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Investigators examined the outcomes of 70 patients with mantle cell lymphoma and included extended follow-up for the 33 initial patients. Grafts were obtained from human leukocyte antigen (HLA)-matched, related donors, unrelated donors, and HLA antigen-mismatched donors. [Cancer] Abstract

Safety of Intracoronary Human Cord Blood Stem Cells in a Lamb Model of Infant Cardiopulmonary Bypass
Investigators evaluated the acute safety, functional effects, and fate of human cord blood mononuclear cells in a novel model of coronary vasculature delivery in a lamb model of infant cardiopulmonary bypass. [Ann Thorac Surg] Abstract

Dendritic Cells Differentiated from Human Umbilical Cord Blood-Derived Monocytes Exhibit Tolerogenic Characteristics
The authors investigated the phenotypes and functions of umbilical cord blood monocyte-derived dendritic cells (DCs) in comparison with those of adult peripheral blood monocyte-derived DCs. [Stem Cells Dev] Abstract

Association between Non-Dominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation
To investigate the associations between non-dominant unit characteristics and neutrophil engraftment, investigators studied 129 consecutive myeloablative double-unit cord blood transplantation recipients. [Biol Blood Marrow Transplant] Abstract

Do Hypoxia/Normoxia Culturing Conditions Change the Neuroregulatory Profile of Wharton Jelly Mesenchymal Stem Cell Secretome?
Scientists examined the effects of normoxic and hypoxic conditions on the human umbilical cord Wharton Jelly-derived mesenchymal stem cells secretome. Subsequently, they addressed the impact of the distinct secretome in the neuronal cell survival and differentiation of human neural progenitor cells. [Stem Cell Res Ther] Abstract

Wound-Healing Potential of Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells In Vitro-A Pilot Study
Researchers compared the wound-healing activity of human umbilical cord blood-derived mesenchymal stromal cells with that of fibroblasts. [Cytotherapy] Abstract

Enhancement of Angiogenic Effects by Hypoxia-Preconditioned Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Mouse Model of Hindlimb Ischemia
Scientists compared the efficacy of hypoxia preconditioned human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and normoxia conditioned hUC-MSCs for the treatment of ischemic injury in hindlimbs of an immunodeficient mouse model. [Cell Biol Int] Abstract

Visit our reviews page to see a complete list of reviews in the cord blood research field.

University of Toronto to Transform Regenerative Medicine Thanks to Historic $114 Million Federal Grant
The University of Toronto is set to cement its position as one of the world’s leading centers for the design and manufacture of cells, tissues and organs that can be used to treat degenerative disease, thanks to a $114-million grant from the federal government. [University of Toronto] Press Release

CDRD & OICR Team up to Advance Cutting-Edge New Cancer Treatments
Two of Canada’s leading drug research and commercialization centers have announced a call for proposals to help bring new cancer treatments to patients through collaborative technology-development projects from academic investigators across Canada. [Center for Drug Research and Development (CDRD)] Press Release

From our sponsor:
Webinar: Brent Reynolds on the identification and characterization of neural stem cells. Watch now.

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

Visit our events page to see a complete list of events in the cord blood community.

NEW Postdoctoral Position – Hematopoietic Stem and Progenitor Cell Assays (Weill Cornell Medical School)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

Principal Scientist – Hematopoietic Products (STEMCELL Technologies Inc.)

Postdoctoral Fellow – Hematopoietic Regeneration and Myeloid Malignancies (Weill-Cornell Medical College)

Research Associate – Cell Biology (Editas Medicine)

Independent Junior Group Leader – Lymphopoiesis or Gene Regulation/Nuclear Architecture in the Hematopoietic System (Max-Planck-Institute)

Clinical Research Coordinator – Chronic Lymphocytic Leukemia (Fred Hutchinson Cancer Research Center)

Regulatory Coordinator – Leukemia Research (Weill Cornell College of Medicine)

PhD Position – Drug Releasing, Nanostructured Biomaterials for Adult Stem Cells (Karlsruhe Institute of Technology)

Postdoctoral Fellow – Immune Reconstitution in Hematopoietic Stem Cell Transplantation (Stanford University)

Research Associate – Leukemia, Stem Cells and Development (Josep Carreras Leukemia Research Institute)

Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.